# A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules

> **NCT05026502** · — · TERMINATED · sponsor: **AbbVie** · enrollment: 23 (actual)

## Conditions studied

- Heavy Menstrual Bleeding
- Uterine Fibroids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05026502
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-05
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Strategic considerations
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05026502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05026502, "A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05026502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*